Drisapersen
DMD115501
Phase 3 small_molecule terminated
Quick answer
Drisapersen for Muscular Dystrophies is a Phase 3 program (small_molecule) at BioMarin International Limited with 2 ClinicalTrials.gov record(s).
Program details
- Company
- BioMarin International Limited
- Indication
- Muscular Dystrophies
- Phase
- Phase 3
- Modality
- small_molecule
- Status
- terminated